101 hits for »HTA «
…payers, academics, and other industry associations. We provide our small and mid-sized biopharmaceutical members a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard…
…HTA procedures. So it’s not something new that we are inventing. I sometimes have the feeling that this is not stressed enough in the political discussions in Brussels.” “We should focus on areas where there are a lack of alternatives and at the same time,…
…Orphan Drugs and ATMPs – and are concurrently convinced to mutually benefit from the newly formed connection in an outstanding network. Especially with the implementation of the European HTA regulation around the corner, we feel that EUCOPE provides an excellent opportunity to actively collaborate, to…
…To this end, we have been educating policymakers about the importance of increased plasma collection and patient access to plasma medicines as a means to promote positive patient outcomes. Other key policies impacting the plasma industry include the OMP regulation, HTA regulation and cross-border health…
…HTA to Digital Health, sharing key highlights and what to expect in 2023. We will be back with more amazing episodes and insights next year, so stay tuned and stay healthy! This episode is hosted by EUCOPE’s Communications & Business Development Manager, Dante Di Iulio…
…and industry thought leaders. This edition will provide the opportunity to discuss a variety of topics, including the EU HTA Regulation, the European Health Data Space, ATMPs, competition trends, and much more! SELECTED SPEAKERS: Andrea Borrell Vila (HERA), Marcus Guardian (EUnetHTA), Attila Sipos (Legal Service),…
…expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures at the EU and Member State level. Learn more about the benefits of membership with EUCOPE. The…
…We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures. Read more……
…on upcoming EU legislative framework. Being represented and having a chance to impact the upcoming legislation on major topics such as EU Pharmaceutical and HTA legislations as well as the revision of the OMP regulation is of primary importance for companies like Enterome which are…
…decision-making. Areas of expertise within EUCOPE include pricing and reimbursement, science and regulatory, health technology assessment (HTA), legal, government/public affairs, rare diseases, orphan drugs, cell and gene therapies, advanced diagnostics, and medical technologies. Awareness Inclusion in the EUCOPE Member Directory Ability to promote webinars, events,…
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information